Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
12
ASPU Quote, Financials, Valuation and Earnings
Last price:
$0.0600
Seasonality move
:
-1.72%
Day range:
$0.0600 - $0.0643
52-week range:
$0.0002 - $0.2499
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
0.06x
Volume:
500
Avg. volume:
30.4K
1-year change:
-64.11%
Market cap:
$1.8M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for ASPU
Dec 05
2025
Most recent earnings per share
-$0.06
Beat by $0.04
(Mar 15/2023)
Consensus Estimate
-$0.10
(Mar 15/2023)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ASPU Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 07/19/2023 | Q2 | $20.3M | -- | -- | -$0.08 | -- |
| 03/15/2023 | Q1 | $19.9M | $15.6M | -$0.06 | -$0.10 | $0.04 |
| 12/14/2022 | Q4 | $15.3M | $17.1M | -$0.09 | -$0.07 | -$0.03 |
| 09/14/2022 | Q3 | $18.6M | $18.9M | -$0.15 | -$0.13 | -$0.02 |
| 07/19/2022 | Q2 | $19.3M | $19.4M | -$0.08 | -$0.09 | $0.01 |
| 03/15/2022 | Q1 | $18.8M | $18.9M | -$0.15 | -$0.09 | -$0.06 |
| 12/14/2021 | Q4 | $19.9M | $18.9M | -$0.11 | -$0.03 | -$0.08 |
| 09/14/2021 | Q3 | $19.2M | $19.4M | -$0.03 | -$0.05 | $0.02 |
| 07/13/2021 | Q2 | $18.7M | $19.1M | -$0.09 | -$0.05 | -$0.05 |
| 03/16/2021 | Q1 | $16.6M | $16.6M | -$0.11 | -$0.04 | -$0.07 |
| 12/15/2020 | Q4 | -- | $17M | -$0.19 | -- | -- |
| 09/14/2020 | Q3 | -- | $15.2M | -$0.04 | -- | -- |
| 07/07/2020 | Q2 | -- | $14.1M | -$0.03 | -- | -- |
| 03/10/2020 | Q1 | -- | $12.5M | -$0.12 | -- | -- |
| 12/10/2019 | Q4 | -- | $12.1M | -$0.03 | -- | -- |
| 09/09/2019 | Q3 | -- | $10.4M | -$0.11 | -- | -- |
| 07/09/2019 | Q2 | -- | $10.2M | -$0.09 | -- | -- |
| 03/11/2019 | Q1 | -- | $8.5M | -$0.13 | -- | -- |
| 12/10/2018 | Q4 | -- | $8.1M | -$0.13 | -- | -- |
| 09/06/2018 | Q3 | -- | $7.2M | -$0.15 | -- | -- |
| 07/12/2018 | Q2 | -- | $7.2M | -$0.25 | -- | -- |
| 03/15/2018 | Q1 | -- | $5.7M | -$0.15 | -- | -- |
| 12/13/2017 | Q4 | -- | $4.9M | -$0.04 | -- | -- |
| 09/14/2017 | Q3 | -- | $4.2M | -$0.06 | -- | -- |
| 04/30/2017 | Q2 | -- | $4.3M | -$0.05 | -- | -- |
| 03/09/2017 | Q1 | -- | $3.7M | $0.00 | -- | -- |
| 12/12/2016 | Q4 | -- | $3.5M | $0.01 | -- | -- |
| 07/31/2016 | Q3 | -- | $2.8M | -$0.04 | -- | -- |
| 04/30/2016 | Q2 | -- | $2.7M | -$0.01 | -- | -- |
| 01/31/2016 | Q1 | -- | $2.2M | -$0.06 | -- | -- |
| 10/31/2015 | Q4 | -- | $1.9M | -$0.07 | -- | -- |
| 07/31/2015 | Q3 | -- | $1.7M | -$0.07 | -- | -- |
Aspen Group Earnings Questions
-
How Much did Aspen Group Generate in Revenue Last Quarter?
Aspen Group reported $15.6M worth of top line sales in its most recent quarter.
-
Did Aspen Group Beat Earnings Last Quarter?
Aspen Group announced earnings per share of -$0.06 which represents a beat of analyst forecast a -$0.10 per share.
-
Is Aspen Group Profitable?
Aspen Group reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Aspen Group EPS Next Year?
Aspen Group's earnings are forecast to decrease from -- per share to -$0.25 per share next year representing a decrease of -18.42%.
-
When is Aspen Group's Earnings Date?
Aspen Group's next earnings date is December 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
